tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Incyte Corp (INCY)
NASDAQ:INCY
US Market
INCY
Incyte
RESEARCH TOOLSreports

Incyte (INCY) Stock News & Sentiment

Compare
1,903 Followers
Incyte: Market Overpenalizes Jakafi LOE as Diversified Pipeline and Emerging Franchises Support Buy Rating and $135 Target
Premium
Ratings
Incyte: Market Overpenalizes Jakafi LOE as Diversified Pipeline and Emerging Franchises Support Buy Rating and $135 Target
5h ago
INCY
Tafasitamab-Parsaclisib Trial Termination Tempers Incyte Outlook
Premium
Company Announcements
Tafasitamab-Parsaclisib Trial Termination Tempers Incyte Outlook
1d ago
INCY
Incyte Advances Microneedle Skin Sampling Platform With Completion of Observational Study in Atopic Dermatitis
Premium
Company Announcements
Incyte Advances Microneedle Skin Sampling Platform With Completion of Observational Study in Atopic Dermatitis
20d ago
INCY
Incyte: Transitioning Beyond Jakafi With a Promising but Unproven Late-Stage Pipeline Warrants Hold Rating
Premium
Ratings
Incyte: Transitioning Beyond Jakafi With a Promising but Unproven Late-Stage Pipeline Warrants Hold Rating
22d ago
INCY
Incyte: Post-Jakafi Revenue Gap and Execution Risks Undermine Confidence, Justifying Sell Rating
Premium
Ratings
Incyte: Post-Jakafi Revenue Gap and Execution Risks Undermine Confidence, Justifying Sell Rating
23d ago
INCY
Balancing Near‑Term Strength and Post‑Jakafi Uncertainty: Why Incyte Merits a Hold Rating
Premium
Ratings
Balancing Near‑Term Strength and Post‑Jakafi Uncertainty: Why Incyte Merits a Hold Rating
23d ago
INCY
Incyte: Diversifying Beyond Jakafi With a High-Value Late-Stage Pipeline and Disciplined Growth Strategy
Premium
Ratings
Incyte: Diversifying Beyond Jakafi With a High-Value Late-Stage Pipeline and Disciplined Growth Strategy
24d ago
INCY
More INCY News >

INCY News on the Web

Tafasitamab-Parsaclisib Trial Termination Tempers Incyte Outlook
TipRanks News
Bearish
Barclays Maintains Overweight Rating on INCY, Raises Price Target to $116 | INCY Stock News
GuruFocus News
Bullish
Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy?
Zacks
Bullish
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks
Bullish
Incyte price target raised to $116 from $115 at Barclays
TipRanks News
Bullish
Barclays Keeps Their Buy Rating on Incyte (INCY)
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Revolution Medicines (RVMD), Roche Holding AG (OtherRHHVF) and Incyte (INCY)
TipRanks News
Neutral
Incyte announces CHMP opinion recommending approval of Zynyz combination
TipRanks News
Bullish

News Score - Last 7 Days

Positive
INCY
Sector Average
Media Buzz
This Week8 articles
Weekly Average5 articles
News Sentiment
This Week83%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INCY’s Media Buzz Sentiment?
8 articles about INCY were published this week. In an average week, 5 articles are published.
    What is INCY’s weekly average amount of articles?
    In an average week, 5 articles about INCY are published.
      What is INCY’s News Sentiment?
      83% of articles about INCY were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        DVADaVita
        TECHBio-Techne
        STARStrides Pharma Science Ltd
        ALGNAlign Tech
        PLXProtalix
        Showing the stocks with the most bullish news sentiment over the past week